Benzinga’s Top Pre-Market NASDAQ Losers (AVNR, CHBT, ASML, CRUS)

Avanir Pharmaceuticals Inc AVNR dipped 6.90% to $2.70 in the pre-market session. AVNR’s trailing-twelve-month operating margin is -604.40%. China-Biotics Inc CHBT lost 3.33% to $11.63 in the pre-market session. CHBT has been ranked 62nd on FORTUNE's 2010 "Fastest-Growing Companies" list. ASML Holding NV ASML fell 2.95% to $24.70 in the pre-market session. Analysts at Deutsche Bank downgraded ASML from "buy" to "hold". Cirrus Logic Inc CRUS slipped 2.30% to $15.27 in pre-market trading. Analysts at Stifel Nicolaus downgraded CRUS from “buy” to “hold.” Read more from Benzinga's Company news.